Johns Hopkins and Partner Cancer Centers Advance New Cancer Treatments
The Johns Hopkins Translational Science Team and Consortium for ETCTN Studies
This program brings together leading cancer centers to find and test new ways to treat cancer for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11074059 on NIH RePORTER |
What this research studies
Our program connects several top cancer centers to speed up the discovery and testing of new cancer medicines. We focus on conducting high-quality clinical trials for promising new treatments, including combinations of drugs or therapies tailored for specific patient groups or rare cancers. This collaborative effort ensures that new treatments are tested efficiently and safely, following strict guidelines. By working together, we aim to bring more effective options to patients facing various types of cancer.
Who could benefit from this research
Good fit: Patients who may qualify for these clinical trials include those with various cancers, especially those seeking novel or experimental anticancer agents.
Not a fit: Patients not seeking experimental treatments or those whose condition does not align with the specific trial criteria may not directly benefit from participation in these particular studies.
Why it matters
Potential benefit: If successful, this collaboration could lead to more effective and personalized treatment options for cancer patients.
How similar studies have performed: This program builds upon established clinical trial networks, suggesting a proven framework for testing new therapies, though the specific agents being tested are novel.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Carducci, Michael a — Johns Hopkins University
- Study coordinator: Carducci, Michael a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.